Top Markets
Coin of the day
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Peringkat dalam Saham #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Harga Saham
$64.97
Terakhir disinkronkan: 2024-05-20
Kapitalisasi Pasar
$1.97B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Alpine Immune Sciences, Inc. (ALPN)

Kategori

Jumlah saham beredar untuk Alpine Immune Sciences, Inc. (ALPN)
Jumlah saham beredar per March 2024: 64.03M
Menurut laporan keuangan terbaru dan harga saham Alpine Immune Sciences, Inc., jumlah saham beredar saat ini adalah 64.03M. Pada akhir December 2022, perusahaan memiliki 33.44M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Alpine Immune Sciences, Inc. (ALPN) dari 2012 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 64.03M 28.07%
2023 50.00M 49.54%
2022 33.44M 31.24%
2021 25.48M 22.33%
2020 20.83M 13.44%
2019 18.36M 32.56%
2018 13.85M 113.67%
2017 6.48M 67.36%
2016 3.87M 65.32%
2015 2.34M 2.70%
2014 2.28M 0.00%
2013 2.28M 0.00%
2012 2.28M 0.00%
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
253.90M 296.51%
US
62.19M -2.89%
NL
478.91M 647.91%
AU
396.00M 518.43%
US
- -
CH